Vera Therapeutics, Inc. (VERA) NASDAQ

22.51

+0.48(+2.18%)

Updated at May 09 10:16AM

Currency In USD

Valuation

Market Cap2.34B
Enterprise Value2.3B
P/E Ratio-7.95
PEG Ratio0.77
Price/Sales Ratio0
Price/Book Ratio2.1
Enterprise/Revenue0
Enterprise/EBITDA-9.4

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.23
Return On Equity-0.39

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-167.17M
Net Income-152.15M
Diluted EPS-2.75

Balance Sheet

Total Cash640.85M
Total Cash/Share11.67
Total Debt54.64M
Total Debt/Equity0.09
Current Ratio25.67
Book Value Per Share10.51

Price History

52-Week Change-47.96
52-Week High51.61
52-Week Low18.53
Moving Average 50 Days24.98
Moving Average 200 Days36.35

Statistics

Average Volume1.1M
Shares Outstanding63.77M
% Held by Institutions114.6

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A